Proteasomal Dysfunction and Endoplasmic Reticulum Stress Enhance Trafficking of Prion Protein Aggregates through the Secretory Pathway and Increase Accumulation of Pathologic Prion Protein*

  1. Hermann M. Schätzl§,2
  1. From the Institute of Virology, Prion Research Group, Technische Universität München, 81675 Munich, Germany,
  2. the §Departments of Veterinary Sciences and Molecular Biology, University of Wyoming, Laramie, Wyoming 82071, and
  3. the Institute for Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institute, 17493 Greifswald-Insel Riems, Riems, Germany
  1. 2 To whom correspondence should be addressed: Depts. of Veterinary Sciences and Molecular Biology, University of Wyoming, MICRO/Molecular Biology, UW Shipping, 16th and Gibbons St., Laramie, WY 82071. Tel.: 307-766-6605; E-mail: hschatzl{at}uwyo.edu.
  • 1 Present address: Deutsches Zentrum für Neurodegenerative Erkrankungen e.V., Bonn, Germany.

Background: It is important to understand whether proteasomal dysfunction and endoplasmic reticulum (ER) stress can influence prion propagation.

Results: Both events lead to an increase of PrP aggregates in the secretory pathway and increased pathologic prion protein in infected cells.

Conclusion: Our data suggest a novel pathway that contributes to prion propagation.

Significance: These findings might be of relevance for the pathogenesis of sporadic prion diseases.

Abstract

A conformational change of the cellular prion protein (PrPc) underlies formation of PrPSc, which is closely associated with pathogenesis and transmission of prion diseases. The precise conformational prerequisites and the cellular environment necessary for this post-translational process remain to be completely elucidated. At steady state, glycosylated PrPc is found primarily at the cell surface, whereas a minor fraction of the population is disposed of by the ER-associated degradation-proteasome pathway. However, chronic ER stress conditions and proteasomal dysfunctions lead to accumulation of aggregation-prone PrP molecules in the cytosol and to neurodegeneration. In this study, we challenged different cell lines by inducing ER stress or inhibiting proteasomal activity and analyzed the subsequent repercussion on PrP metabolism, focusing on PrP in the secretory pathway. Both events led to enhanced detection of PrP aggregates and a significant increase of PrPSc in persistently prion-infected cells, which could be reversed by overexpression of proteins of the cellular quality control. Remarkably, upon proteasomal impairment, an increased fraction of misfolded, fully glycosylated PrP molecules traveled through the secretory pathway and reached the plasma membrane. These findings suggest a novel pathway that possibly provides additional substrate and template necessary for prion formation when protein clearance by the proteasome is impaired.

Footnotes

  • * This work was also supported by Deutsche Forschungsgemeinschaft Scha594/7-1, SFB-596 (Project A8), and Alberta Prion Research Institute, Alberta, Canada (Projects 20080238 and 20090122).

  • Graphic The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3.

  • Received June 15, 2011.
  • Revision received August 5, 2011.
Table of Contents

Submit your work to JBC.

You'll be in good company.